Genpact Limited (G)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 513,670 | 631,255 | 353,404 | 369,448 | 308,276 |
| Total stockholders’ equity | US$ in thousands | 2,389,610 | 2,248,390 | 1,826,160 | 1,897,130 | 1,834,230 |
| ROE | 21.50% | 28.08% | 19.35% | 19.47% | 16.81% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $513,670K ÷ $2,389,610K
= 21.50%
Genpact Limited has shown a consistent improvement in its return on equity (ROE) from 16.81% as of December 31, 2020, to 21.50% as of December 31, 2024. This indicates the company's ability to generate stronger returns for its shareholders over the years. The significant increase in ROE from 2020 to 2023, peaking at 28.08% on December 31, 2023, suggests a period of particularly efficient utilization of shareholders' equity to generate profits. However, the slight decrease in ROE to 21.50% by the end of 2024 may indicate a potential slowdown in the company's profitability or efficiency compared to the peak year of 2023. Overall, Genpact Limited's ROE trend demonstrates commendable performance in generating returns for shareholders over the analyzed period.
Peer comparison
Dec 31, 2024